Correlia Biosystems, Inc. — Form D
Correlia Biosystems, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-09. The offering totals $3.3M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-05-09
- Form: D
- Accession: 0001827990-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $1.3M
- Remaining: $2.0M
- Investors: 2
- Date of first sale: 2023-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-481248
Issuer
- Name: Correlia Biosystems, Inc.
- CIK: 0001827990
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 626 BANCROFT WAY, BERKELEY, CA, 94710
- Phone: 510-859-4577
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Akwasi Apori | Director | Berkeley, CA |
| Kursad Araz | Director | Berkeley, CA |
| Kittu Kolluri | Director | Berkeley, CA |
| Akwasi Apori | Executive Officer | Berkeley, CA |
| Samuel Tia | Director | Berkeley, CA |
Other filings by this issuer (1)
More